Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sepsis × Meropenem × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Febrile Neutropenia 3 Neoplasms 2 Urinary Bladder Neoplasms 1 Sepsis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Other Infectious Diseases 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Emergencies 1

Interventions

Anti-Bacterial Agents 2 ziprasidone 1 telavancin 1 soybean oil, phospholipid emulsion 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Povidone-Iodine 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Multiplex Polymerase Chain Reaction 1 Molindone 1 Methylprednisolone 1 Methods 1 Meropenem 1 Massage 1 Lurasidone Hydrochloride 1 Levofloxacin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05393505 2022-12-06

FRANCiS-NF

The University of Hong Kong

Phase 4 Unknown

Classical hematology

Emergencies, Neoplasms, Sepsis, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡